会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Process for the currentless deposition of electropositive metal layers
on the surfaces of less electropositive metals
    • 在正电性较小的金属表面上无电沉积正电性金属层的方法
    • US4908241A
    • 1990-03-13
    • US222386
    • 1988-07-21
    • Helmut QuastJohannes RaberWalter OttHans-Georg von SchneringKarl Peters
    • Helmut QuastJohannes RaberWalter OttHans-Georg von SchneringKarl Peters
    • C23C18/38C23C18/40C23C18/42C23C18/44
    • C23C18/42C23C18/38
    • The present invention provides a process for the currentless deposition oflectropositive metal layers on to appropriate less electropositive metals by contacting an object to be coated with a coating bath, wherein a coating bath is used which contains a metal complex obtained by reacting a monovalent electropositive metal halide with a base, which is capable of complex formation with the electropositive metal, and a hydrohalic acid.The present invention also provides a coating bath for the currentless deposition of electropositive metal layers on to less electropositive metals, wherein said bath contains an electropositive metal complex obtained by reacting a monovalent electropositive metal halide with a base which is capable of complex formation with the electropositive metal and a hydrohalic acid.Furthermore, the present invention provides an electropositive metal complex, obtainable by the reaction of a monovalent electropositive metal halide with a base which is capable of complex formation with the electropositive metal and a hydrohalic acid, followed by precipitation from the reaction mixture.
    • 本发明提供了一种通过使待涂覆物体与涂层浴接触而使正电性金属层无电沉积到适当的少正电性金属的方法,其中使用包含通过使单价正电性金属 具有能与正电性金属复合形成的碱的卤化物和氢卤酸。 本发明还提供了一种用于将正电性金属层无电沉积至较少正电性金属的涂层浴,其中所述浴含有通过使正电性金属卤化物与能够与正电性复合形成的碱反应获得的正电性金属络合物 金属和氢卤酸。 此外,本发明提供一种正电性金属络合物,其可以通过使一价正电性金属卤化物与能与正电性金属和氢卤酸形成复合物的碱反应,然后从反应混合物中沉淀而得到。
    • 5. 发明授权
    • Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
    • 针对排斥指导分子(RGM)的抗体的治疗用途
    • US07981420B2
    • 2011-07-19
    • US10451586
    • 2001-12-21
    • Bernhard K. MuellerPhilippe P. MonnierPaolo MacchiFriedrich BonhoefferBernd StahlMatthias MannJens S. Anderson
    • Bernhard K. MuellerPhilippe P. MonnierPaolo MacchiFriedrich BonhoefferBernd StahlMatthias MannJens S. Anderson
    • A61K39/395C07K16/28
    • C07K14/47A61K38/1709A61K2039/505C07K14/465C07K14/4702C07K16/28
    • The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardio-vascular system. Furthermore, the invention provides for the use of a modulator of a polypeptide having or comprising said amino acid sequence of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with angiogenic disorders or disorders of the cardio-vascular system. In addition the invention provides for the use of said polypeptide or said functional fragment or derivative thereof for the preparation of a pharmaceutical composition for preventing or treating tumor growth or formation of tumor metastases or as a marker of stem cells.
    • 本发明涉及具有或包含本文公开的氨基酸序列或其功能片段或衍生物或编码所述多肽或片段或衍生物的多核苷酸的调节剂用于制备药物组合物的用途 预防,减轻或治疗与癫痫相关的脊椎动物神经组织的退化或损伤相关的疾病或病症或与心血管系统的血管生成障碍或病症有关。 此外,本发明提供了具有或包含其功能片段或其衍生物的所述氨基酸序列或编码所述多肽或片段或衍生物的多核苷酸的多肽的调节剂用于制备用于预防,缓解的药物组合物 或治疗与脊髓动物神经组织的变性或损伤相关的疾病或病症,与血管生成障碍或心血管系统的病症有关。 此外,本发明提供了所述多肽或其功能片段或其衍生物用于制备用于预防或治疗肿瘤生长或肿瘤转移形成或作为干细胞标记的药物组合物的用途。